Therapeutic Advances in Hematology

Published by: Sage Publications  

People

  1. Rampal
    Rampal
  2. Salles
    Salles
  3. Mauro
    Mauro
  4. Palomba
    Palomba

Groups

  1. Department of Medicine (7)
  2. Hematologic Malignancies, Division of (7)
  3. Center for Hematologic Malignancies (5)
  4. Adult Leukemia (4)
  5. Hematology-Oncology Fellows (3)
  6. GME, Medicine (2)
  7. Graduate Medical Education (2)
  8. CTCR Scholars (1)
  9. Lymphoma (1)
  10. MSK Grad Students (1)
Search Within
Formats
  1. Review (6)
  2. Journal Article (3)
Groups
  1. Department of Medicine (7)
  2. Hematologic Malignancies, Division of (7)
  3. Center for Hematologic Malignancies (5)
  4. Adult Leukemia (4)
  5. Hematology-Oncology Fellows (3)
  6. GME, Medicine (2)

More Groups

People
  1. Gilles Salles (2)
  2. Raajit Rampal (2)
  3. Anthony Mato (1)
  4. Gottfried Von Keudell (1)
  5. Helen Ajufo (1)
  6. Jan Bewersdorf (1)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publishers
  1. Sage Publications (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine
    Journal Article

    Zeidan, A. M.; Bewersdorf, J. P.; Hasle, V.; Shallis, R. M.; Thompson, E.; de Menezes, D. L.; Rose, S.; Boss, I.; Halene, S.; Haferlach, T.; more...
    Therapeutic Advances in Hematology (2024)

    Fulltext@MSK | Save
  • Interferons in the treatment of myeloproliferative neoplasms
    Review

    Vachhani, P.; Mascarenhas, J.; Bose, P.; Hobbs, G.; Yacoub, A.; Palmer, J. M.; Gerds, A. T.; Masarova, L.; Kuykendall, A. T.; Rampal, R. K.; more...
    Therapeutic Advances in Hematology (2024)

    Fulltext@MSK | Save
  • Treating accelerated and blast phase myeloproliferative neoplasms: Progress and challenges
    Review

    Ajufo, H. O.; Waksal, J. A.; Mascarenhas, J. O.; Rampal, R. K.
    Therapeutic Advances in Hematology (2023)

    Fulltext@MSK | Save
  • The potential of pirtobrutinib in multiple B-cell malignancies
    Review

    Jensen, J. L.; Mato, A. R.; Pena, C.; Roeker, L. E.; Coombs, C. C.
    Therapeutic Advances in Hematology (2022)

    Fulltext@MSK | Save
  • The use of tafasitamab in diffuse large B-cell lymphoma
    Review

    Düll, J.; Topp, M.; Salles, G.
    Therapeutic Advances in Hematology (2021)

    Fulltext@MSK | Save
  • The role of tazemetostat in relapsed/refractory follicular lymphoma
    Review

    von Keudell, G.; Salles, G.
    Therapeutic Advances in Hematology (2021)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: Opinion, evidence, and recommendations
    Journal Article

    Abruzzese, E.; Mauro, M.; Apperley, J.; Chelysheva, E.
    Therapeutic Advances in Hematology (2020)

    Fulltext@MSK | Save
  • Epigenetic therapy combinations in acute myeloid leukemia: What are the options?
    Review

    Bewersdorf, J. P.; Shallis, R.; Stahl, M.; Zeidan, A. M.
    Therapeutic Advances in Hematology (2019)

    Fulltext@MSK | Save
  • Ibrutinib in Waldenstrom macroglobulinemia: Latest evidence and clinical experience
    Journal Article

    Castillo, J. J.; Palomba, M. L.; Advani, R.; Treon, S. P.
    Therapeutic Advances in Hematology (2016)

    Fulltext@MSK | Save

    • Therapeutic Advances in Hematology – authorized name for:

    Name ISSN / ISBN Publisher
    Therapeutic Advances in Hematology 20406207 The Author(s), 2023
    Therapeutic Advances in Hematology 20406207 The Author(s), 2021
    Therapeutic Advances in Hematology 20406207 The Author(s), 2024
    Therapeutic Advances in Hematology 20406207 Unknown
    Therapeutic Advances in Hematology 20406207 The Author(s), 2022
    Therapeutic Advances in Hematology 2040-6207 Sage Publications
    Therapeutic Advances in Hematology 2040-6207 Sage Publications